🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II study of the combination of All-Trans Retinonic Acid (AT...
Status
Recruiting
Location
University of Pennsylvania
Start Date
2022-11-16
Trial ID
NCT05345002
Treatments Being Tested
This study is a Phase 3 global, multicenter, placebo-controlled double-blin...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2021-01-12
Trial ID
NCT04472429
Treatments Being Tested
This study is investigating the optimal dose and the advantage in combining...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-08-30
Trial ID
NCT06290622
Treatments Being Tested
This phase II trial tests how well a combination of three immunotherapy dru...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-11-08
Trial ID
NCT06056895
This phase I/II trial tests the safety, side effects best dose and effect o...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-06-23
Trial ID
NCT07468136
This is a study of the combination of 9 ING-41 (elraglusib) and retifanlima...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2025-09-22
Trial ID
NCT06896188
Treatments Being Tested
The investigators will evaluate the sensitivity of ctDNA from plasma and CS...
Status
Recruiting
Location
Johns Hopkins
Start Date
2025-04-07
Trial ID
NCT06610682
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of platinum-...
Status
Completed
Location
Pacific Cancer Medical Center
Start Date
2020-09-11
Trial ID
NCT04205812
Treatments Being Tested
This phase II trial tests how well retifanlimab with bevacizumab and hypofr...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-10-02
Trial ID
NCT06160206
The purpose of this study is to assess the safety and tolerability and to d...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-07-15
Trial ID
NCT03920839
Treatments Being Tested